Literature DB >> 9705610

IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release.

U Westin1, E Lundberg, K Ohlsson.   

Abstract

The secretory leukocyte protease inhibitor (SLPI) is a low-molecular-weight inhibitor of proteases, such as elastase and cathepsin G which are released from leukocytes during phagocytosis. The purpose of this study was to determine whether or not SLPI is able to inhibit IgE-mediated histamine release. Nasal mucosa from 11 test subjects without atopic disposition was used for this in vitro study. We found that SLPI inhibited histamine release in a dose-dependent way but was without influence on the spontaneous release.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705610      PMCID: PMC1781850          DOI: 10.1080/09629359891162

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  25 in total

1.  Antibody and inhibitor of chymase inhibit histamine release in immunoglobulin E-activated mast cells.

Authors:  H Kido; N Fukusen; N Katunuma
Journal:  Biochem Int       Date:  1985-06

2.  The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor.

Authors:  U Seemüller; M Arnhold; H Fritz; K Wiedenmann; W Machleidt; R Heinzel; H Appelhans; H G Gassen; F Lottspeich
Journal:  FEBS Lett       Date:  1986-04-07       Impact factor: 4.124

3.  [On a hormone dependent inhibitor of proteolytic enzymes in male accessory sex glands and in sperm].

Authors:  H Haendle; H Fritz; I Trautschold; E Werle
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1965

Review 4.  Mediators of immediate hypersensitivity.

Authors:  S I Wasserman
Journal:  J Allergy Clin Immunol       Date:  1983-08       Impact factor: 10.793

5.  Properties of protease in mast cell granules.

Authors:  S Okuno-Kaneda; T Saito; Y Kawasaki; A Ichikawa; K Tomita
Journal:  Biochem Pharmacol       Date:  1980-06-15       Impact factor: 5.858

6.  Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease.

Authors:  B Schick; K F Austen; L B Schwartz
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

7.  Granulocyte collagenase, elastase and plasma protease inhibitors in purulent sputum.

Authors:  K Ohlsson; H Tegner
Journal:  Eur J Clin Invest       Date:  1975-06-12       Impact factor: 4.686

8.  Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor.

Authors:  K Ohlsson; H Tegner
Journal:  Scand J Clin Lab Invest       Date:  1976-09       Impact factor: 1.713

9.  Effect of human leukocyte enzymes on tracheal mucosa and its mucociliary activity.

Authors:  H Tegner; K Ohlsson; N G Toremalm; C von Mecklenburg
Journal:  Rhinology       Date:  1979-09       Impact factor: 3.681

10.  Characteristics of histamine release from cultured human mast cells.

Authors:  Y Igarashi; M Kurosawa; O Ishikawa; Y Miyachi; H Saito; M Ebisawa; Y Iikura; M Yanagida; H Uzumaki; T Nakahata
Journal:  Clin Exp Allergy       Date:  1996-05       Impact factor: 5.018

View more
  2 in total

1.  Secretory leukocyte protease inhibitor plays an important role in the regulation of allergic asthma in mice.

Authors:  Rafael Marino; Thusanth Thuraisingam; Pierre Camateros; Cynthia Kanagaratham; Yong Zhong Xu; Jennifer Henri; Jingxuan Yang; Guoan He; Aihao Ding; Danuta Radzioch
Journal:  J Immunol       Date:  2011-02-18       Impact factor: 5.422

2.  Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro.

Authors:  Camilla Hollander; Max Nyström; Sabina Janciauskiene; Ulla Westin
Journal:  Cancer Cell Int       Date:  2003-08-20       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.